GLOBUS MEDICAL INC (GMED) Cash flow
Market cap
$12.5B
P/E ratio
23.7x
| 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 18 | 19 | 22 | 24 | 39 | 42 | 42 | 53 | 63 | 70 | 68 | 145 | 254 | 277 |
| Stock-based compensation | 5 | 5 | 7 | 10 | 11 | 15 | 22 | 26 | 27 | 31 | 33 | 53 | 54 | 50 |
| Cash from operations | 77 | 93 | 79 | 122 | 172 | 160 | 182 | 172 | 199 | 276 | 178 | 243 | 521 | 753 |
| Capital expenditures | -25 | -24 | -25 | -51 | -41 | -51 | -60 | -71 | -64 | -57 | -74 | -78 | -115 | -165 |
| Cash from investing | -31 | -227 | -100 | -151 | -100 | -111 | -193 | -140 | -117 | -376 | -110 | 303 | -176 | -355 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | 105 | - | 144 | 226 | 86 | 300 |
| Repayments of term debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | 24 | 11 | 13 | 6 | 2 | 2 | 33 | 24 | -39 | 54 | -110 | -232 | -28 | -679 |
| Free cash flow | ||||||||||||||
| FCF margin (%) |